Mangoceuticals
MGRX
18 hedge funds and large institutions have $1.88M invested in Mangoceuticals in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
129% more capital invested
Capital invested by funds: $820K → $1.88M (+$1.06M)
64% more funds holding
Funds holding: 11 → 18 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.49M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$483K |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$224K |
| 4 |
Jane Street
New York
|
+$77K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$74.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$62.4K |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$4.59K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$112 |
MGRX Hedge Fund Activity: Q4 2025 in Review
18 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q4 2025, worth a combined $1.88M — up 129% from $820K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MGRX positions and 3 closed out — a net gain of 7 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $2.49M. The largest seller was XTX Topco, exiting entirely with an estimated $62.4K sold.
- 18 institutional investors held Mangoceuticals (MGRX) as of Q4 2025, up from 11 in Q3 2025.
- Funds reported $1.88M of Mangoceuticals stock for Q4 2025, up 129% quarter-over-quarter.
- 10 funds opened new Mangoceuticals positions in Q4 2025 and 3 closed out, a net change of +7 holders.
- The largest Mangoceuticals buyer in Q4 2025 was Armistice Capital, an estimated $2.49M added.
- The largest Mangoceuticals seller in Q4 2025 was XTX Topco, an estimated $62.4K sold.
Based on aggregated 13F filings for Q4 2025.